Oncolytics Biotech Inc ONCY

Both Roche and Incyte have turned me down as an MSL

[Noteable]

Go figure !

[fox7mf]

I just read on renaissancecapital.com that yesterday Adlai Nortye filed with the SEC a US IPO for $115m.

[itntdf]

this taken from the sec filing: Other programs AN1004 Pelareorep, or AN1004, is an intravenously delivered oncolytic virus. We own the exclusive rights to AN1004 in China, Singapore, and South Korea through an in-licensing agreement with Oncolytics Biotech, Inc. Ongoing Phase Ib clinical trial of AN1004 in combination with atezolizumab and gemcitabine/nab-paclitaxel demonstrated encouraging

[westcoast1000]

Thanks for this useful comment, ITNTDF. It shows pela has not fallen out of favor with AN. This FUD has been spread by many posters here and elsewhere.

[fox7mf]

Maybe Adlai is maneuvering to take a run at owning Oncy outright. They say they want to be a leader in the next wave of immuno oncology and Pela is just that. They'd need backing to pull off such a huge acquisition tho...perhaps Japan's Takeda? 

[fox7mf]

Adlai and a partnering foreign BP could put a $25b deal together for Oncy and the FTC would not be able to say squat about it;)

[jimsenior]

A closer look at AN. Two drugs appear to be at their forefront. Buparlisib  -  AN2025.  Palupiprant -  AN0025. AN2025 has been in 90 trials or more. AN2025 and AN0025 and Tecentriq are involved in an interesting Double/Triple that is progressing very nicely. NCT04975958. Fair to assume a strong connection to Roche. AN0025 and Keytruda are being tested together. So a